| |
|
| Source: Company documents |
|
|
| Name
: |
Xiaodong Wu |
| Title
: |
Chairman of the Board, Chief Executive Officer |
| Since: |
|
|
|
|
|
| Name
: |
Takyung Tsang |
| Title
: |
Chief Financial Officer, Director |
| Since: |
01/2005 |
|
|
|
|
| Name
: |
Zhong Chen |
| Title
: |
Chief Technology Officer |
| Since: |
11/2007 |
|
|
|
|
| Name
: |
Feng Zhu |
| Title
: |
Vice President - Business Development and Investor Relationship |
| Since: |
01/2005 |
|
|
|
|
|
|
|
| |
|
| Earnings
Release Dates : 4th August 2008 , 12th June 2008 , 28th February 2008 , 20th November 2007 |
|
 Audio |
|
|
| |
|
| |
|
| |
|
| |
| Chindex Plunges 27%, China Medical Rises 17% Jun 12, 12:53 PM EDT |
| Two of the Three IPOs Trade Above Offering Price Aug 27, 10:13 AM ET |
| Late-Summer IPO Rush Continues Aug 13, 11:03 AM ET |
|
| |
China Medical Technologies, Inc.
The Company’s primary product, the HIFU therapy system, is an ultrasound-guided ablation system that is used for the non-invasive treatment of solid tumors. The Company’s system is designed to destroy tumors by using HIFU waves to instantly raise the temperature of the targeted tumor tissue to between 60° C and 70° C (140° F and 158° F). The Company’s proprietary designs enable the system to treat a wide range of tumors, many of which cannot be treated with other HIFU tumor therapy devices currently available in the market.
|
| More... |
|
|
|
